Kimberly Tableman: Does true transformation in trials start with the clinical protocol?

Transformation in Trials

This week we are hosting Kimberly Tableman, Founder and CEO of ESPERO Health, and speak about how clinical trial protocols are being re-imagined in our industry. We dive into what a protocol actually is and what it describes.

Protocols are currently being developed with a lot of manual research. WIth googling, phoning friends and re-using existing protocols in word documents.

Trials today are being conducted in a more complex environment than before. This means that it is necessary to adapt the trial design as the trial is executed. Creating a trial and executing it unchanged is becoming more rare and requirements for additional digitization in this space are increasing.

Trial design is also a very collaborative process involving 10-12 stakeholders. Using a system that supports collaborative creation is key to avoid the pitfalls of versioning and overwriting of comments.

Writing the protocol with data collected from the current market can make the protocol more robust and accelerate timelines. That is what Espiro health aims to provide in their protocol platform. Making it easy is the trick to ensure adoption.

We also speak about the dynamics that lead to rigidity in the pharmaceutical space and how having sufficient inflow of money in especially big pharma leads to containing the status quo.

Speaking out of her experience as a founder, we dive into what it means to start a technology company in the life sciences space and how funding is key to getting off the ground.

Guest:

Kimberly Tableman

https://www.linkedin.com/in/kimberly-tableman/

ESPERO Health

https://www.linkedin.com/company/espero-health/

________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page